Literature DB >> 1203896

Synergistic interaction of anticancer agents: a cellular perspective.

F Valeriote, H s Lin.   

Abstract

Mesh:

Substances:

Year:  1975        PMID: 1203896

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


× No keyword cloud information.
  55 in total

1.  Experimental combination chemotherapy with thymidylate synthetase and ribonucleotide reductase inhibitors.

Authors:  S Kobayashi; T Hoshino; D V Santi
Journal:  Pharm Res       Date:  1984-07       Impact factor: 4.200

2.  The development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors.

Authors:  Corey P Causey; Justin E Jones; Jessica L Slack; Daisuke Kamei; Larry E Jones; Venkataraman Subramanian; Bryan Knuckley; Pedram Ebrahimi; Alexander A Chumanevich; Yuan Luo; Hiroshi Hashimoto; Mamoru Sato; Lorne J Hofseth; Paul R Thompson
Journal:  J Med Chem       Date:  2011-09-16       Impact factor: 7.446

Review 3.  Cancer chemotherapy: new strategies for success.

Authors:  N A Berger
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

4.  Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice.

Authors:  R F Schinazi; J Peters; C C Williams; D Chance; A J Nahmias
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

5.  Antiproliferative activity of 2-[N, N-bis-(2-chloroethyl)-amino]-4-[2-sulfonato-ethylthio]-tetrah ydr o-2H-1 , 3,2-oxazaphosphorine-2-oxide cyclohexamine (ASTA Z 7557, INN mafosfamide) against human and murine tumor cells in vitro.

Authors:  J S Kovach; P A Svingen
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

6.  Improved synthesis of histone deacetylase inhibitors (HDIs) (MS-275 and CI-994) and inhibitory effects of HDIs alone or in combination with RAMBAs or retinoids on growth of human LNCaP prostate cancer cells and tumor xenografts.

Authors:  Lalji K Gediya; Aashvini Belosay; Aakanksha Khandelwal; Puranik Purushottamachar; Vincent C O Njar
Journal:  Bioorg Med Chem       Date:  2007-12-08       Impact factor: 3.641

7.  Cytotoxicity of combinations of prostaglandin D2 (PGD2) and antitumor drugs for B16 melanoma cells in culture.

Authors:  B K Bhuyan; G J Badiner; E G Adams; R Chase
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

8.  In vitro studies on drug interaction of ifosfamide and ACNU in primary and metastatic human brain tumours.

Authors:  U Bogdahn; D Drenkard; M Lutz; R Apfel; C Behl
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

9.  Combined effects of UFT with other anticancer agents using in vivo chemosensitivity tests.

Authors:  M Nishiyama; K Niimi; S Takagami; N Hirabayashi; M Yamaguchi; T Saeki; K Yoshinaka; D C Wang; M Niimoto; T Hattori
Journal:  Jpn J Surg       Date:  1988-01

10.  Effects of scheduling and ascites-associated macrophages on combined antiproliferative activity of alpha-2b interferon and gamma-interferon in a clonogenic assay.

Authors:  J Higashihara; T Saito; M E Berens; C E Welander
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.